Background illustration for clinical trials search

Kidney Cancer Clinical Trials

Browse 250 kidney cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

for
Cutaneous Squamous Cell Carcinoma, Skin Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07426484

Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Louisville KY,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase 1, Phase 2, Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Zion IL, St Louis MO, Houston TX, Goodyear AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07594106

Phase 1, Phase 2, Recruiting

A Study of Luspatercept in People With Anemia

for
Anemia, Chronic Kidney Disease
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07725497

Phase 2, Recruiting

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

for
Chronic Kidney Disease, Stage 4,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18 - 65

Code: NCT06741072

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

for
Small Cell Lung Cancer, Renal Cell Carcinoma (RCC),
Location: Cleveland OH, Birmingham AL, St Louis MO
Sponsor: Advenchen Pharmaceuticals, LLC.

Sex: All

Age: 18+

Code: NCT05363280

Phase 2, Recruiting

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

for
Advanced Biliary Tract Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT07405086

Phase 4, Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase 1, Recruiting

Pilot Trial of Supplemental Vitamin A and Nicotinamide

for
Skin Cancer, Kidney Transplant Recipients
Location: Providence RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT05702398

Early Phase 1, Recruiting

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology

for
Liver Cancer (Primary and Metastatic), Renal Cancer
Location: Palo Alto CA
Sponsor: Palo Alto Veterans Institute for Research

Sex: All

Age: 18+

Code: NCT07303725

Recruiting

Sacituzumab Govitecan Plus EV in Metastatic UC

for
Urothelial Cancer, Metastatic Urothelial Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04724018

Phase 1, Phase 2, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Philadelphia PA, Wilson NC, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase 2, Recruiting

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

for
Localized Clear Cell Renal Cell Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07226544

Phase 2, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Atlanta GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase 1, Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

for
Sarcoma, Endocrine Tumors, Neuroblastoma, Retinoblastoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT01109394

Recruiting

Imaging of Solid Tumors Using 18F-TRX

for
Solid Tumor, Solid Carcinoma,
Location: San Francisco CA
Sponsor: Rahul Aggarwal

Sex: All

Age: 18+

Code: NCT06942104

Phase 1, Recruiting

A Natural History Study of Metabolic Sizing in Health and Disease

for
Metabolic Disorders, Cancer, Chronic Kidney Disease, Diabetes,
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 2 - 70+

Code: NCT05398783

Recruiting

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

for
Metastatic Bladder Urothelial Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07087860

Phase 2, Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

for
Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC),
Location: Lake Success NY, Pittsburgh PA, Jacksonville FL,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT07419841

Phase 1, Recruiting